Recent Posts

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating

Others have already stopped sales, like Eden, which has created a special landing page declaring compounded tirzepatide to be “banned nationwide!” Ro, one of the most prominent telehealth companies in the space, has also stopped offering the product. “We are working to ensure our patients have the best options available …

Read More »